SCHEMBL21192541

SCHEMBL21192541

Clc1c[nH]c(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7106017 0.69 — —
SCHEMBL4150325 0.69 — —
SCHEMBL28399850 0.65 — —
SCHEMBL21737078 0.65 — —
SCHEMBL21192537 0.65 — —
SCHEMBL5174484 0.65 — —
SCHEMBL21737178 0.65 — —
SCHEMBL5270227 0.61 — —
SCHEMBL21719660 0.60 GABRA1 (0.33) —
SCHEMBL20844172 0.60 DAO (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116601131-A CTPS1 inhibitor and application thereof 林伯士克洛索有限公司 2023-08-15 — — CN disclosed
US-20230008117-A1 LIGHT EMITTING DIODE SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-12 — — US disclosed
US-20230008117-A1 LIGHT EMITTING DIODE SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-12 — — US disclosed
CN-115440906-A Light emitting diode 三星显示有限公司 2022-12-06 — — CN disclosed
CN-109476649-B Five-membered heterocyclic compound and preparation method, pharmaceutical composition and application thereof 苏州苏领生物医药有限公司 2022-07-08 — — CN disclosed
EP-3515912-A1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES Centre National De La Recherche Scientifique (FR) 2019-07-31 — — EP disclosed
Send feedback